Rifampin inhibits the initiation of transcription and has been widely used in the studies on the mechanism of ribonucleic acid (RNA) synthesis in bacteria (see reference 10). It is known that wild-type yeast cells are resistant to this antibiotic. Recently, we isolated and partly characterized several sorbitol-dependent fragile mutants of Saccharomyces cerevisiae, which grow exponentially in the presence of sorbitol but break open and release up to 90% of their RNA when resuspended in low-salt buffers (13) . One of these fragile mutants, VY1160, derived from the parental S288 wild strain, showed a higher sensitivity to rifampin.
Here we report results on the synthesis of different RNA species in the VY1160 fragile yeast mutant in the presence of rifampin. High concentrations of rifampin cause an early arrest in the synthesis of all types of RNA, followed by an inhibition of protein synthesis. Lower concentrations of rifampin inhibit preferentially the synthesis of ribosomal RNA (rRNA) in comparison to that of messenger RNA (mRNA) and transport RNA (tRNA). Partially purified yeast RNA polymerase II from this mutant is inhibited by low concentrations of rifampin.
MATERIALS AND METHODS
The fragile yeast mutant VY1160 was used. Media and conditions of cultivation have been described (13) . RNA and protein synthesis in whole cells were determined by labeling cultures with either [3H]uracil or a 14C-labeled amino acids mixture and measuring 5% trichloroacetic acidprecipitable radioactivity. All samples were filtered through Whatman GF/C glass-fiber disks, washed with cold 5% trichloroacetic acid, dried, and counted with a toluene-2,5-diphenyloxazole (PPO)-1,4-bis-(4-methyl-5-phenyloxazole-2-yl-benzene) (dimethyl-POPOP) phosphor (toluene, 1 liter, PPO, 5 g, dimethyl-POPOP, 0.25 g) in a Packard Tri-Carb 3320 spectrometer.
Isolation of total RNA. The cells were harvested and suspended in one-fifth of the culture volume of 0.01 M NaCl, 0.01 M ethylenediaminetetraacetate (pH 7.0), 1% sodium dodecyl sulfate. The RNA was extracted with an equal volume of phenol saturated with 0.14 M NaCl (pH 6.0) for 15 min at 60 C. After cooling and centrifugation for 15 min at 5,000 x g, the water phase was deproteinized with phenol containing 10% chloroform for 15 min at 25 C. The RNA from the final water phase was precipitated with 2 volumes of 95% ethanol, containing 1% potassium acetate, at -10 C. The yield was about 1 absorbancy unit at 260 nm of RNA per 5 x 106 cells. The RNA was analyzed by agar-gel electrophoresis (11) . The absorbancy of the dried agar-gel plates was recorded at 260 nm with a recording spectrodensitometer. The dried agar-gel plates were cut in 2-mm slices, and RNA was hydrolyzed with 5% NH-OH for 18 h at 37 C and counted with a toluene-PPO-dimethyl-POPOP phosphor (as above) containing 30% Triton X-100. Polyadenylic acid [poly(A)]-containing mRNA was separated from total RNA by the use of an oligo(dT)-cellulose column (5).
Analysis of polysomes. To 10 ml of a log-phase culture, 0.1 "Ci of [14C]uracil per ml was added to label stable RNA. After 4 h of cultivation, 2 gCi of [3H]uracil per ml was added, and the culture was incubated further for 15 min. The cells were collected and suspended in 1 ml of 10 mM tris(hydroxymethyl)aminomethane (Tris)-hydrochloride (pH 7.8) 627 628 VENKOV, MILCHEV, AND HADJIOLOV containing 10 mM MgCl2 for 3 min to achieve uniform lysis. The suspension was centrifuged at 9,000 x g for 15 min, and sodium deoxycholate and Brj 58 were added to the supernatant to a final concentration of 0.5% each. The supernatant was layered on a linear 10 to 30% sucrose density gradient in 10 mM Tris-hydrochloride (pH 7.8), containing 10 mM MgCl2 and 30 mM NaCl. The gradients were centrifuged for 5 h at 25,000 rpm in the SW27 rotor of a Beckman L-65B ultracentrifuge. Fractions of 0.8 ml were pumped from the bottom of the gradients, precipitated with an equal volume of 10% trichloroacetic acid, filtered on Whatman GF/C glass-fiber disks, and counted.
Induction of a-glucosidase. The activity of a-glucosidase was determined according to van Wik et al. (12) using maltose as inducer, and the hydrolysis rate of the chromogenic substrate, p-nitrophenyl-a-D-glucopyranoside, was used as a measure for a-glucosidase activity. The protein content of the cell lysate was assayed by the method of Lowry et al. (7) . The lag between the addition of the inducer and the initiation of enzyme synthesis, about 40 min in yeast protoplasts (12) , is only about 15 min in the fragile VY1160 mutant. Thirty minutes after the induction of VY1160 cells with maltose, the enzyme activity in cell lysates was about 10-fold higher than the basal level in noninduced cells.
Isolation and determination of RNA polymerase. Total RNA polymerase activity was assayed in crude lysates from VY1160 cells. Cells were lysed in water at 4 C, and the obtained lysate was immediately adjusted to 50 mM Tris-hydrochloride, (pH 7.9), 80% (vol/vol) glycerol, 2 mM ethylenediaminetetraacetate, 5 mM ,-mercaptoethanol, and 0.5 M (NH.)280. The unlysed cells and cell debris were separated by centrifugation for 15 min at 5,000 x g. The supernatant (1 to 2 mg of protein per ml) was freed from low-molecular-weight substances by passage through Sephadex G100 equilibrated with the same buffer.
RNA polymerases I and II were isolated from lysates of whole VY1160 cells and separated by chromatography on diethylaminoethyl-Sephadex A25 according to Adman et al. (1) . Aliquots from the column fractions were assayed for enzyme activity in the absence or presence of 20 ,ug of a-amanitin per ml. The standard incubation mixture for determination of RNA-polymerase activity contains, in Figure 2 shows the time dependence of rifampin action on RNA and protein synthesis in VY1160. The inhibitory effect is observed as early as 5 min after addition of the antibiotic. Protein synthesis is also inhibited, but only after a lag period of more than 10 min. It should be noted that, even at high concentrations of rifampin that block RNA synthesis completely, proteins continue to be labeled at a decreasing rate for about 60 min.
Effect of rifampin on the synthesis of different RNA species. The observation of a plateau in the action of increasing concentrations of rifampin on RNA synthesis (see Fig. 1 tein synthesis, suggested a selective in vivo action of rifampin on the synthesis of a particular RNA species. The inhibition of the synthesis of different RNA species by increasing concentrations of rifampin is shown in Table 1 . Concentrations higher than 300 ,ug/ml of culture (5.10w cells) caused an almost complete inhibition of all three RNA species. However, rifampin concentrations of 50 to 200 ,g/ml inhibit preferentially the synthesis of rRNA as compared to that of mRNA and tRNA ( Table 1) .
The inhibition of [methyl-3H]methionine labeling of rRNA (Table 1 ) might have been due to an inhibition of methylation rather than to a decreased rRNA synthesis. To obtain direct evidence for the preferential inhibition ofrRNA synthesis by rifampin, two types of experiments were carried out.
First, the polysome profile of VY1160 cells, short-term labeled with [3Hluracil in the presence or absence of rifampin (200 jug/ml), was analyzed (Fig. 3) . Newly synthesized RNA from the control appears in polysomes, monosomes, free ribosomal subparticles, and slower sedimenting tRNA. However, RNA made in the presence of rifampin mainly enters the polysome fraction, whereas very little radioactivity is seen in the region of monosomes and free subparticles.
In the second type of experiments, growing VY1160 cells were labeled with [3Hluracil for 15 min with or without 200 pg of rifampin per ml. Total RNA was isolated from both cultures and analyzed by agar-gel electrophoresis (Fig.  4) . The labeling profile of total RNA from the control shows the three main peaks of stable RNA, i.e., 25S, 18S, and tRNA. A rapidly labeled, heterogeneous RNA fraction [retained by oligo(dT)-cellulose] overlaps with the two rRNA peaks. This heterogeneous RNA is the main species labeled in the presence of rifampin (Fig. 4B) . The bulk of this heterogeneous RNA, labeled in the presence of rifampin, is retained by oligo(dT)-cellulose and therefore represents poly(A)-containing mRNA (data not shown). The label in tRNA from rifampintreated cells is inhibited to about 50%, which is in good agreement with data obtained by [methyl-3Hlmethionine labeling ( Table 1 ). The two types of experiments described above provide conclusive evidence that the synthesis of rRNA in vivo in the VY1160 yeast mutant is more susceptible to rifampin as compared to the synthesis of mRNA and tRNA.
Induction of a-glucosidase in the presence of rifampin. Enzyme induction requires the de novo synthesis of mRNA. As shown above, 200 pg of rifampin per ml blocks rRNA synthesis, whereas mRNA continues to be made at about one-half the control rate. The synthesis offunctional mRNA in the presence ofrifampin was studied by following the induction of a- (9 ,000 x g supernatant fluid) was layered over a 10 to 30% sucrose density gradient as described in Materials and Methods. The 3H and 14C counts precipitated with cold 5% trichloroacetic acid were determined. The 3H counts in each gradient fraction from the culture treated with rifampin were normalized against the 14C counts of the corresponding fraction from the culture without rifampin. The "4C (A) and 3H (-) counts from the control culture and the 3H (0) counts from the rifampin-treated culture are plotted. Inhibition of VY1160 yeast RNA polymerases by rifampin. The effect of rifampin on RNA polymerases was studied with crude cell lysates and purified enzymes from VY1160 cells. RNA polymerases I and II in crude cell lysates were distinguished by their susceptibility to a-amanitin. In agreement with previous authors (4, 14) , both RNA polymerases from the parental s288 wild-type strain were resistant to rifampicin, tested at concentrations up to 100 jug/ml. In contrast, the RNA polymerase II activity from lysates of the VY1160 mutant was strongly inhibited by rifampin, the effect of the drug being fully displayed at 1 ,ug/ml. The results presented in Table 3 show that purified RNA polymerase II is markedly more a Ten-milliliter VY1160 cultures in the log growth phase were induced with 2% maltose. Rifampin and maltose were added simultaneously. The cells were harvested at 30 min after induction, washed with cold 10% sorbitol, and lysed in 1 ml of distilled water. Cell debris were removed by centrifugation for 5 min at 5,000 x g, and the supernatant was collected. The lysates contained 0.4 to 0.5 mg of protein per ml and were used directly for determination of a-glucosidase activity. susceptible to rifampin than RNA polymerase I. In a series of independent experiments, puIified RNA polymerase II was inhibited to about 15 to 30% residual activity by 1 ,ug of rifampin per ml. On the other hand, a-amanitin-resistant RNA polymerase I was inhibited only to 80 to 90% residual activity by this concentration of rifampin. Experiments with crude cell lysates yielded essentially the same results. These results show that the partly purified RNA polymerase II from the VY1160 mutant strain is inhibited by rifampin at concentrations similar to those inhibiting Escherichia coli RNA polymerase (10) . The possibility of cross-contamination of polymerases I and II does not permit one to conclude whether the observed slight inhibition of RNA polymerase I is significant or not. In any case, the inhibition of RNA polymerase II by rifampin is markedly more pronounced than that of RNA polymerase I. DISCUSSION The in vivo synthesis of RNA in yeast cells appears to be susceptible to rifampin, as shown by amphotericin B-potentiated permeability of wild-type yeast (8) . These results are confirmed in our present work, but the osmotic-susceptible mutant VY1160 is several-fold more susceptible to rifampin without the synergetic action of amphotericin B. The mutant VY1160 was isolated as a rifampin-susceptible colony on an enriched media plate containing 10% sorbitol (13) , which might explain its higher susceptibility to rifampin. Thus, the action of rifampin may be explained by an increased cell wall permeability and/or alterations in RNA polymerases conferring rifampin susceptibility to these enzymes. Our results show that partly purified RNA polymerase II from the VY1160 mutant is inhibited by rifampin at concentrations comparable to those reported for E. coli polymerase (10) . These results were unexpected in view of the reported unsusceptibility of purified yeast RNA polymerases I and II to rifampin (4, 14) . At present, we cannot decide whether the RNA polymerase II of VY1160 mutant is itself mutated to rifampin susceptibility, or, alternatively, whether the RNA polymerase preparations obtained by the above-quoted authors (4, 14) have lost some factor required for rifampin susceptibility of the enzyme during purification. The second possibility remains open since VY1160 mutant is lysed under milder conditions, with a minimal release of nuclease or protease activities (data to be published).
The in vivo action of rifampin at lower doses displays a preferential inhibition of rRNA synthesis as compared to that of mRNA and tRNA. Even at complete inhibition of rRNA synthesis, protein synthesis continues and functional mRNA is made, as evidenced by the possibility of a-glucosidase induction. Therefore, rifampin does not interfere directly with cellular protein synthesis. The higher in vivo susceptibility of rRNA synthesis in the VY1160 mutant cannot be correlated with the in vitro effect of rifampin as a stronger inhibitor of RNA polymerase II. Consequently, the in vivo action of rifampin may involve additional mechanisms participating in the transcription of rRNA genes or ribosome biogenesis. It should be noted that a similar difference in the in vivo and in vitro action of the rifamycin derivative AF013 (and other related derivatives) was reported also with HeLa cells (2) .
